Why Pfizer is intent on a double dose of AstraZeneca By: CNBC.com News May 05, 2014 at 22:48 PM EDT British drug maker AstraZeneca may have rejected a $106 billion takeover bid from Pfizer, but the U.S. company is likely to get its way in the end. Read More >> Related Stocks: Astrazeneca Plc ADR Pfizer